Polymorphic form of glp-1r agonist, preparation method therefor and use thereof
AssigneeMindrank Therapeutics (Suzhou) New Drug Research and Development Co., Ltd
InventorsLong ZHANG, Zhangming NIU, Yang HU
Life of this patent
Estimating the term…
Abstract
A polymorphic form of a GLP-1R agonist compound (III), a preparation method therefor and a use thereof are provided. Compared with an amorphous form of compound (III), the polymorphic form has higher stability and better processability, and is more suitable for preparing a drug for preventing or treating diseases related to a GLP-1R target and a signaling pathway thereof, such as type 2 diabetes, prediabetes, obesity, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, kidney disease, gout, hyperhematuria, cardiovascular disease, etc.
Claims10
A polymorph of compound III,
- wherein, X is Cl or CN.
Dependencies are inferred from the claim text.